| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1311471B1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 04/12/2006 | EP1075261B1 Mycobacterial inhibitors |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1759100A New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate |
| 04/12/2006 | CN1757646A Inhibitors of nucleoside metabolism |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/12/2006 | CN1250505C Improved method for preparing 1-propyl-2, 4, 5-trimethoxy benzene |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026350 Water-soluble drugs and methods for their production |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026345 Resolution of 3-amino alkylnitriles |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7025819 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 04/11/2006 | CA2229470C Process for the purification of an intermediate in the preparation of iopamidol |
| 04/06/2006 | WO2006036664A1 Substituted sulfonamidopropionamides and methods of use |
| 04/06/2006 | WO2006036350A1 Method for purifying n-(2-hydroxyethyl)-2-pyrrolidone |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006004724A3 A method for preparing pyrrolotriazine compounds |
| 04/06/2006 | WO2005049532A3 A process for purification |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | DE102004047869A1 Verfahren zur enzymatischen Synthese von Pyroglutaminsäureestern A process for the enzymatic synthesis of esters of pyroglutamic acid |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2580461A1 Substituted sulfonamidopropionamides and methods of use |
| 04/05/2006 | EP1642894A1 Quaternary ammonium salt, electrolyte, and electrochemical device |
| 04/05/2006 | EP1642891A1 - |
| 04/05/2006 | EP1642880A1 Hsp90 family protein inhibitors |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641753A1 Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate |
| 04/05/2006 | EP1641752A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| 04/05/2006 | EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/05/2006 | EP1245564B1 Benzamidine derivatives |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1756741A Lipid metabolism improving agent |
| 04/05/2006 | CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 04/05/2006 | CN1756734A Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754877A Anthracene derivative and organic electroluminescence device using the derivative |
| 04/05/2006 | CN1249210C Asymmetrical imide bleaching activators and compositions employing the same |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249032C Production method of N-octa alkyl-2-pyrrolidone |
| 04/05/2006 | CN1249018C Triaryl methane compounds for sickle cell disease |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/04/2006 | US7022863 Production method of pyrrolidone carboxylic acid and salt thereof |
| 04/04/2006 | US7022862 aldehyde-pyrrole catalytic condensation leading to dipyrromethanes as a crystalline solid or as intermediates used for making porphyrin compounds; non-aqueous process |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022786 Ligands, complexes and their use for the polymerization of olefins |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022703 Acetylenic compound useful in treating inflammatory disorders |
| 04/04/2006 | US7022421 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 04/04/2006 | CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | WO2006033714A2 Metal chelators and methods of their use |
| 03/30/2006 | WO2006033355A1 Oral pharmaceutical for dry skin prevention or remedy |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006032959A2 Processes for the preparation of pyrrole derivatives |
| 03/30/2006 | WO2006032893A2 Trityl derivatives for enhancing mass spectrometry |
| 03/30/2006 | WO2005105738A3 Salt forms of atorvastatin |
| 03/30/2006 | US20060069284 Esters of allyl substituted by a difluoromethylene group, method for the synthesis thereof and use thereof |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | CA2580757A1 Orally administered agent for preventing or improving dry state of skin |
| 03/30/2006 | CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 03/29/2006 | EP1640364A1 Process for producing nitrogenous heterocyclic compound |
| 03/29/2006 | EP1639029A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638940A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 03/29/2006 | EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/29/2006 | EP1638936A1 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 03/29/2006 | EP1638935A1 Nk1 antagonist |
| 03/29/2006 | EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 03/29/2006 | EP1638933A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 03/29/2006 | EP1638932A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 03/29/2006 | EP1638551A2 Immunosuppressant compounds and compositions |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1753868A Novel compounds and compositions containing the same |
| 03/29/2006 | CN1753668A 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 03/29/2006 | CN1752084A Heterocycle containing fluorene kind derivative and its preparation method |
| 03/29/2006 | CN1752075A Structure modified product of biosource compound and its use in weed control |
| 03/29/2006 | CN1752074A Intermediate N-protection-(2S,4S)-2-[(3-hydroxyl carbonyl)-phenyl amino formyl)]-pyrrolidine-4-thio alcohol of ertabeinan |
| 03/29/2006 | CN1752073A Preparatino method of (2S,4S)-1-(4-nitro carbobenzoyl)-2-[(3-allyloxycarbonyl)-phenyl aminoformyl]-pyrrolidine -4-thioalcohol |
| 03/29/2006 | CN1247581C Processes for the preparation of carbapenem-type antibacterial agents |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247541C Cyclic imines as pesticides |
| 03/29/2006 | CN1247540C Levo-1-ethyl-2-aminomethylpentazane preparation method |
| 03/28/2006 | US7019127 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018642 Compounds, compositions, and methods for controlling biofilms |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |